Inactive Instrument

Analyst Reco. THOE HEAL

Equities

Evercore ISI Downgrades Thorne HealthTech to In Line From Outperform, Raises Price Target to $10.20 From $8	23-10-11	MT
TD Cowen Downgrades Thorne HealthTech to Market Perform From Outperform, Adjusts Price Target to $10.20 From $8	23-08-30	MT
Canaccord Genuity Adjusts Price Target on Thorne HealthTech to $7 From $6, Maintains Buy Rating	23-08-11	MT
Canaccord Genuity Adjusts Price Target on Thorne HealthTech to $6 From $5.50, Keeps Buy Rating	23-04-04	MT
Canaccord Genuity Starts Thorne HealthTech at Buy With $5.50 Price Target	22-11-17	MT
RBC Cuts Price Target on Thorne HealthTech to $6 From $8, Maintains Outperform Rating	22-11-11	MT
Cowen Adjusts Price Target on Thorne HealthTech to $8 From $12, Keeps Outperform Rating	22-08-11	MT
RBC Cuts Price Target on Thorne HealthTech to $8 From $11, Maintains Outperform Rating	22-08-11	MT
THORNE HEALTHTECH : Evercore ISI Starts Thorne HealthTech at Outperform with $13 Price Target	21-10-18	MT
THORNE HEALTHTECH : BofA Securities Initiates Coverage on Thorne HealthTech With Buy Rating, $11 Price Target	21-10-18	MT
THORNE HEALTHTECH : RBC Initiates Thorne HealthTech at Outperform, Sets Price Target at $11	21-10-18	MT
THORNE HEALTHTECH : Cowen Starts Thorne HealthTech at Outperform With $11 Price Target	21-10-18	MT

No results for this search